Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study.
Haas M, Jakubovski E, Fremer C, Dietrich A, Hoekstra PJ, Jäger B, Müller-Vahl KR; EMTICS Collaborative Group.
Front Psychiatry. 2021 Feb 25;12:626459. doi: 10.3389/fpsyt.2021.626459. eCollection 2021.
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment.
Szejko N, Robinson S, Hartmann A, Ganos C, Debes NM, Skov L, Haas M, Rizzo R, Stern J, Münchau A, Czernecki V, Dietrich A, Murphy TL, Martino D, Tarnok Z, Hedderly T, Müller-Vahl KR, Cath DC.
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):383-402. doi: 10.1007/s00787-021-01842-2. Epub 2021 Oct 18.
Revisiting the structure of the Yale Global Tic Severity Scale (YGTSS) in a sample of Chinese children with tic disorders.
Wen F, Gu Y, Yan J, Liu J, Wang F, Yu L, Li Y, Cui Y.
BMC Psychiatry. 2021 Aug 9;21(1):394. doi: 10.1186/s12888-021-03399-5.
Is the Yale Global Tic Severity Scale a valid tool for parent-reported assessment in the paediatric population? A prospective observational study in Taiwan.
Ho CS, Huang JY, Yang CH, Lin YJ, Huang MY, Su YC.
BMJ Open. 2020 Aug 20;10(8):e034634. doi: 10.1136/bmjopen-2019-034634.
A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale.
McGuire JF, Piacentini J, Storch EA, Murphy TK, Ricketts EJ, Woods DW, Walkup JW, Peterson AL, Wilhelm S, Lewin AB, McCracken JT, Leckman JF, Scahill L.
Neurology. 2018 May 8;90(19):e1711-e1719. doi: 10.1212/WNL.0000000000005474. Epub 2018 Apr 13.
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Lasch F, Guizzaro L, Aguirre Dávila L, Müller-Vahl K, Koch A.
Pharm Stat. 2021 May;20(3):675-691. doi: 10.1002/pst.2100. Epub 2021 Feb 16.
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.
Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ.
J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73. doi: 10.1097/00004583-198907000-00015.
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.
Mosley PE, Webb L, Suraev A, Hingston L, Turnbull T, Foster K, Ballard E, Gomes L, Mohan A, Sachdev PS, Kevin R, Gordon R, Benson M, McGregor IS.
NEJM Evid. 2023 Sep;2(9):EVIDoa2300012. doi: 10.1056/EVIDoa2300012. Epub 2023 Jun 7.
Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale.
Storch EA, De Nadai AS, Lewin AB, McGuire JF, Jones AM, Mutch PJ, Shytle RD, Murphy TK.
J Child Adolesc Psychopharmacol. 2011 Dec;21(6):621-7. doi: 10.1089/cap.2010.0149. Epub 2011 Nov 9.
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions.
Andrén P, Jakubovski E, Murphy TL, Woitecki K, Tarnok Z, Zimmerman-Brenner S, van de Griendt J, Debes NM, Viefhaus P, Robinson S, Roessner V, Ganos C, Szejko N, Müller-Vahl KR, Cath D, Hartmann A, Verdellen C.
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):403-423. doi: 10.1007/s00787-021-01845-z. Epub 2021 Jul 27.
